| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562161137P | 2015-05-13 | 2015-05-13 | |
| US201562256052P | 2015-11-16 | 2015-11-16 |
| Publication Number | Publication Date |
|---|---|
| SG10202003100XAtrue SG10202003100XA (en) | 2020-05-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202003100XASG10202003100XA (en) | 2015-05-13 | 2016-05-13 | Bacteria Engineered to Reduce Hyperphenylalaninemia |
| Country | Link |
|---|---|
| US (6) | US10195234B2 (en) |
| EP (2) | EP3882259A1 (en) |
| JP (3) | JP6843768B2 (en) |
| AU (3) | AU2016262569B9 (en) |
| BR (1) | BR112017024384A2 (en) |
| CA (1) | CA2985819A1 (en) |
| ES (1) | ES2881384T3 (en) |
| IL (2) | IL296538A (en) |
| PL (1) | PL3294760T3 (en) |
| SG (1) | SG10202003100XA (en) |
| WO (1) | WO2016183531A1 (en) |
| ZA (1) | ZA201707678B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10869898B2 (en) | 2014-04-01 | 2020-12-22 | Rubius Therapeutics, Inc. | Methods and compositions for immunomodulation |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| WO2016183532A1 (en)* | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to treat a disease or disorder |
| US20160206666A1 (en) | 2014-12-22 | 2016-07-21 | Synlogic, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier |
| KR102138209B1 (en) | 2015-05-06 | 2020-07-28 | 스니프르 테크놀로지스 리미티드 | Microbial population change and microbial population modification |
| SG10202003100XA (en) | 2015-05-13 | 2020-05-28 | Synlogic Operating Co Inc | Bacteria Engineered to Reduce Hyperphenylalaninemia |
| US11883439B2 (en) | 2015-05-13 | 2024-01-30 | Synlogic Operating Company, Inc. | Bacteria engineered to treat a disease or disorder |
| US11685925B2 (en) | 2015-10-30 | 2023-06-27 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| AU2016356684C1 (en)* | 2015-11-16 | 2022-11-10 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
| US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
| EP3554518A4 (en) | 2016-12-15 | 2020-07-29 | The Board of Trustees of the Leland Stanford Junior University | COMPOSITIONS AND METHOD FOR MODULATING THE GROWTH OF A GENETICALLY MODIFIED COLORED BOWTER CELL |
| US11384358B2 (en) | 2017-03-29 | 2022-07-12 | President And Fellows Of Harvard College | Method of regulating gene expression in a cell |
| US20180362590A1 (en)* | 2017-04-14 | 2018-12-20 | Synthetic Genomics, Inc. | Polypeptides with type v crispr activity and uses thereof |
| IL271085B2 (en)* | 2017-06-21 | 2024-07-01 | Synlogic Operating Co Inc | Bacteria to treat disorders |
| WO2019047166A1 (en) | 2017-09-08 | 2019-03-14 | New Portal Limited | Nucleic acid systems that enable bacteria to specifically target solid tumors via glucose-dependent viability |
| US10849938B2 (en) | 2017-09-13 | 2020-12-01 | ZBiotics Company | Gene expression system for probiotic microorganisms |
| CN107904222B (en)* | 2017-11-30 | 2019-10-08 | 江南大学 | A kind of l-amino acid deaminase mutant and its construction method that thermal stability improves |
| US12163135B2 (en) | 2017-12-05 | 2024-12-10 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| JP2022512380A (en) | 2018-12-10 | 2022-02-03 | ノヴォム バイオテクノロジーズ，インコーポレイテッド | Methods and Compositions for Treating Hyperoxaluria |
| US20220047654A1 (en)* | 2018-12-20 | 2022-02-17 | University Of South Carolina | Pharmabiotic treatments for metabolic disorders |
| EP3963046A1 (en) | 2019-04-29 | 2022-03-09 | Synlogic Operating Company, Inc. | Enumeration of genetically engineered microorganisms by live cell counting techniques |
| CA3142608A1 (en) | 2019-06-04 | 2020-12-10 | Cocoon Biotech Inc. | Silk-based products, formulations, and methods of use |
| CA3144416A1 (en)* | 2019-06-21 | 2020-12-24 | Synlogic Operating Company, Inc. | Optimized bacteria engineered to treat disorders involving the catabolism of leucine, isoleucine, and/or valine |
| CN110257291B (en)* | 2019-06-25 | 2021-07-23 | 北京大学 | A Chromobacterium strain resistant to nickel ion toxicity and its application |
| US20220340621A1 (en) | 2019-09-27 | 2022-10-27 | Intrexon Actobiotics Nv D/B/A Precigen Actobio | Treatment of celiac disease |
| CN116249779A (en) | 2019-11-12 | 2023-06-09 | 阿克蒂姆治疗有限公司 | Immunostimulatory bacteria delivery platform and use thereof for delivering therapeutic products |
| US20230340035A1 (en) | 2020-01-17 | 2023-10-26 | Université Catholique de Louvain | Genetically modified bacterium with altered envelop integrity and uses thereof |
| EP4110283A4 (en)* | 2020-02-25 | 2024-02-28 | Synlogic Operating Company, Inc. | RECOMBINANT BACTERIA MANIPULATED FOR THE TREATMENT OF URIC ACID-ASSOCIATED DISEASES AND METHOD OF USE THEREOF |
| IL295353A (en) | 2020-03-20 | 2022-10-01 | Synlogic Operating Co Inc | Microorganisms engineered to reduce hyperphenylalaninemia |
| WO2021207647A1 (en)* | 2020-04-09 | 2021-10-14 | Computational International LLC | Small molecule drugs as targeted therapeutics |
| EP4176053A4 (en)* | 2020-07-02 | 2024-12-25 | The Regents of the University of California | PERSISTENT MEMORY T CELL RESPONSES TO CANCER AND INFECTIOUS DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID CATABOLISM PATHWAYS |
| EP4196139A2 (en) | 2020-08-12 | 2023-06-21 | Actym Therapeutics, Inc. | Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platforms |
| WO2022103673A2 (en)* | 2020-11-10 | 2022-05-19 | Fridkis Hareli Masha | Compositions of embedded epitope random peptides (eerp) for treatment of immune-mediated conditions, and methods of use |
| US20240110191A1 (en) | 2020-12-02 | 2024-04-04 | Synlogic Operating Company, Inc. | Engineered microorganisms |
| CN112501098B (en)* | 2020-12-11 | 2023-01-03 | 上海陶宇晟生物技术有限责任公司 | Engineering probiotics with phenylalanine degrading capability |
| EP4271806A1 (en) | 2020-12-31 | 2023-11-08 | Synlogic Operating Company, Inc. | Microorganisms engineered to reduce hyperphenylalaninemia |
| CN112662606A (en)* | 2021-01-06 | 2021-04-16 | 中国科学院分子植物科学卓越创新中心 | Engineering probiotics for treating phenylketonuria |
| CN112662607A (en)* | 2021-01-07 | 2021-04-16 | 上海陶宇晟生物技术有限责任公司 | Engineering probiotics with surface display of phenylalanine ammonia lyase |
| JP2024526149A (en)* | 2021-06-24 | 2024-07-17 | ロンザ・グリーンウッド・エルエルシー | Method for controlling administration of an active substance to the gastrointestinal tract - Patents.com |
| EP4429682A2 (en) | 2021-11-09 | 2024-09-18 | Actym Therapeutics, Inc. | Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatment |
| CN116836899A (en)* | 2022-03-02 | 2023-10-03 | 和度生物技术(上海)有限公司 | An engineered microorganism for treating hyperphenylalaninemia and its use |
| CN114717172B (en)* | 2022-03-21 | 2022-09-23 | 江南大学 | Escherichia coli for synthesizing L-valine and construction method and application thereof |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
| CN116463362B (en)* | 2023-06-15 | 2023-09-19 | 中国中医科学院中药研究所 | Preparation method of cell division inhibitor |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9107305D0 (en) | 1991-04-08 | 1991-05-22 | Unilever Plc | Probiotic |
| CN1154845A (en) | 1996-09-09 | 1997-07-23 | 首都医学院附属北京红十字朝阳医院 | Genetic engineering fungus oral prepration capable of expressing active phenylalanine deaminase |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6203797B1 (en) | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
| WO2000032748A1 (en) | 1998-12-02 | 2000-06-08 | Trustees Of Boston University | Gene networks for control of gene expression |
| EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| JP4682454B2 (en) | 2000-06-28 | 2011-05-11 | 味の素株式会社 | Process for producing novel mutant N-acetylglutamate synthase and L-arginine |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| ES2266515T3 (en) | 2001-05-03 | 2007-03-01 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | LACTOCOCCUS strain with self-containment. |
| US7314974B2 (en) | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
| US7731976B2 (en) | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
| JP4452914B2 (en) | 2003-09-08 | 2010-04-21 | 味の素株式会社 | Novel transporter protein |
| AU2005321630A1 (en) | 2004-07-02 | 2006-07-06 | Metanomics Gmbh | Process for the production of fine chemicals |
| JP2008513027A (en) | 2004-09-17 | 2008-05-01 | バイオマリン ファーマシューティカル インコーポレイテッド | Phenylalanine ammonia-lyase variants and chemically modified variants |
| ZA200704766B (en) | 2004-11-30 | 2008-09-25 | Aeras Global Tb Vaccine Found | Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof |
| GB0501540D0 (en) | 2005-01-25 | 2005-03-02 | Univ Leeds | Controlled production and delivery of biologically active agents by gut bacteria |
| US20090038023A1 (en) | 2005-03-10 | 2009-02-05 | Verenium Corporation | Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| EP2029739A4 (en) | 2006-06-02 | 2009-11-25 | Verenium Corp | Lase enzymes, nucleic acids encoding them and methods for making and using them |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| US9084434B2 (en) | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| US20100297249A1 (en) | 2007-07-05 | 2010-11-25 | North-West University | Enhancement of the efficacy of therapeutic proteins |
| CN101586111B (en)* | 2008-05-22 | 2012-03-07 | 北京三元基因工程有限公司 | Method for preparing product of active lactic acid galactococcus |
| EP3933029A3 (en) | 2008-09-29 | 2022-03-23 | Intrexon Actobiotics NV | Reduced colonization of microbes at the mucosa |
| US8937215B2 (en) | 2009-08-04 | 2015-01-20 | Evogene Ltd. | Polynucleotides and polypeptides for increasing desirable plant qualities |
| WO2011080505A2 (en) | 2009-12-28 | 2011-07-07 | Bigdna Ltd | Method of growing phage for commercial use |
| US9353173B2 (en) | 2010-03-02 | 2016-05-31 | Renaissance Bioscience Corp. | Functional enhancement of microorganisms to minimize production of acrylamide |
| US8129170B1 (en) | 2010-12-06 | 2012-03-06 | E.I. Du Pont De Nemours And Company | Recombinant bacteria having the ability to metabolize sucrose |
| WO2012088461A2 (en) | 2010-12-23 | 2012-06-28 | Biogen Idec Inc. | Linker peptides and polypeptides comprising same |
| US9017961B2 (en) | 2012-03-05 | 2015-04-28 | E.I. Du Pont De Nemours And Company | Recombinant bacteria comprising novel sucrose transporters |
| FR2990699B1 (en) | 2012-05-21 | 2016-02-05 | Agronomique Inst Nat Rech | PROKARYOTIC EXPRESSION CASSETTES REGULATED BY STRESS |
| ES2709217T3 (en)* | 2012-06-22 | 2019-04-15 | Phytogene Inc | Enzymes and methods for the synthesis of styrene |
| AU2013295621A1 (en)* | 2012-07-27 | 2015-03-12 | University Of North Texas | Genetically modified probiotic for the treatment of phenylketonuria (PKU) disease |
| WO2014066945A1 (en)* | 2012-11-01 | 2014-05-08 | The Sydney Children's Hospital Network (Randwick & Westmead) | Genetically-modified probiotic for treatment of phenylketonuria |
| CA2894710A1 (en) | 2012-12-13 | 2014-06-19 | Massachusetts Institute Of Technology | Recombinase-based logic and memory systems |
| US9951340B2 (en) | 2013-03-07 | 2018-04-24 | The General Hospital Corporation | Compositions and methods for bacterial delivery of polypeptides |
| EA034034B1 (en) | 2013-04-18 | 2019-12-20 | Кодексис, Инк. | Engineered phenylalanine ammonia-lyase polypeptides |
| WO2016183532A1 (en) | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to treat a disease or disorder |
| KR102493174B1 (en)* | 2014-12-05 | 2023-01-27 | 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 | Bacteria engineered to treat diseases associated with hyperammonemia |
| US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
| SG10202003100XA (en) | 2015-05-13 | 2020-05-28 | Synlogic Operating Co Inc | Bacteria Engineered to Reduce Hyperphenylalaninemia |
| WO2016189121A1 (en) | 2015-05-28 | 2016-12-01 | Evolva Sa | Biosynthesis of phenylpropanoids and phenylpropanoid derivatives |
| AU2016276973B2 (en)* | 2015-06-10 | 2022-09-01 | Synlogic Operating Company, Inc. | Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid |
| WO2016210373A2 (en) | 2015-06-24 | 2016-12-29 | Synlogic, Inc. | Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof |
| US20170216370A1 (en) | 2015-07-31 | 2017-08-03 | Synlogic, Inc. | Bacteria engineered to treat disorders involving propionate catabolism |
| AU2016356684C1 (en) | 2015-11-16 | 2022-11-10 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| CN109311953A (en) | 2016-06-13 | 2019-02-05 | 本森希尔生物系统股份有限公司 | Increase plant growth and yield using phenylalanine deaminase sequence |
| IL271085B2 (en) | 2017-06-21 | 2024-07-01 | Synlogic Operating Co Inc | Bacteria to treat disorders |
| CA3105916A1 (en) | 2018-07-12 | 2020-01-16 | Codexis, Inc. | Engineered phenylalanine ammonia lyase polypeptides |
| IL295353A (en) | 2020-03-20 | 2022-10-01 | Synlogic Operating Co Inc | Microorganisms engineered to reduce hyperphenylalaninemia |
| EP4271806A1 (en) | 2020-12-31 | 2023-11-08 | Synlogic Operating Company, Inc. | Microorganisms engineered to reduce hyperphenylalaninemia |
| WO2023044479A1 (en) | 2021-09-17 | 2023-03-23 | Synlogic Operating Company, Inc. | Methods for reducing hyperphenylalaninemia |
| Publication | Publication Date | Title |
|---|---|---|
| ZA201707678B (en) | Bacteria engineered to reduce hyperphenylalaninemia | |
| IL278150A (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
| PL3377518T3 (en) | Bacteria engineered to reduce hyperphenylalaninemia | |
| IL256499A (en) | Antibodies to cd40 | |
| GB2541833B (en) | Improvements to implant surfaces | |
| GB201514489D0 (en) | Hyperphenylalaninemia | |
| IL256432A (en) | 6-amino-quinoline-3-carbonitrils as cot modulators | |
| GB201409541D0 (en) | Probiotic Bacteria | |
| GB201408039D0 (en) | Culture dish | |
| GB201515330D0 (en) | Bioreactor condenser | |
| ZA201802390B (en) | Improved fermenter | |
| GB201519450D0 (en) | Novel treatment | |
| GB201514420D0 (en) | Bioreactor | |
| GB201520827D0 (en) | Bioreactor | |
| GB2538045B (en) | Improvements to letter-plates | |
| GB201514734D0 (en) | Mechanical bioreactor | |
| IL256199A (en) | Multi-peptide composition | |
| GB2522473B (en) | Improvements to windposts | |
| GB201517420D0 (en) | Improvements to bedpans | |
| GB201518810D0 (en) | Bioreactor | |
| GB201517290D0 (en) | Bioreactor | |
| GB201521028D0 (en) | Improvements to Li-fi | |
| GB2520781B (en) | Improvements to hydro-turbines | |
| GB201501181D0 (en) | Ready-to-assemble pond | |
| PL3137475T3 (en) | Purification of epidaunorubicin |